It also demonstrated benefits across multiple manifestations of psoriasis, including itch, nail and scalp involvement, and quality of life measures. In patients with psoriatic arthritis ...

Amgen has won FDA approval for a stronger label for its oral plaque psoriasis therapy Otezla, as it prepares for competition from Bristol-Myers Squibb's much-touted rival deucravacitinib ...